BUHPF: AI 评分 47/100 — AI 分析 (4月 2026)

Bumrungrad Hospital Public Company Limited operates healthcare facilities in Thailand and internationally, offering a wide range of medical services. With a strong focus on patient care and advanced medical technologies, the company has established itself as a leading healthcare provider in the region.

Key Facts: AI Score: 47/100 Sector: Healthcare

公司概况

概要：

Bumrungrad Hospital, a leading healthcare provider based in Thailand, offers comprehensive medical services with a focus on international patients. Operating with 580 beds and numerous specialized clinics, the company distinguishes itself through high-quality care and advanced medical technologies, reflected in its strong profit margin of 29.8% and a substantial dividend yield of 8.41%.

BUHPF是做什么的？

Founded in 1980 and headquartered in Bangkok, Thailand, Bumrungrad Hospital Public Company Limited has evolved into a prominent healthcare provider, offering a broad spectrum of medical services both domestically and internationally. The company operates a large medical center equipped with diagnostic, therapeutic, and intensive care facilities. Its extensive network includes approximately 56 outpatient clinics and centers, covering a wide array of specialties such as allergy, cardiology, oncology, orthopedics, and women's health. Bumrungrad distinguishes itself by catering to a diverse patient base, including a significant number of international patients seeking specialized medical treatments and services. Beyond its core hospital operations, Bumrungrad is involved in real estate asset management, clinical research services, and the distribution of pharmaceutical and medical goods through specialized stores. The company also operates a personnel development and training center to ensure high standards of healthcare service delivery and manages a patient referral service business to facilitate access to its medical expertise. With 580 beds, Bumrungrad Hospital is equipped to handle a large volume of patients, providing comprehensive care across various medical disciplines.

BUHPF的投资论点是什么？

Bumrungrad Hospital presents a compelling investment case due to its established market position, strong financial performance, and growth opportunities in the healthcare sector. The company's high profit margin of 29.8% and dividend yield of 8.41% indicate financial stability and shareholder value. Key growth catalysts include increasing demand for healthcare services in Thailand and the expansion of its international patient base. The company's focus on specialized medical treatments and advanced technologies positions it favorably in a competitive market. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations affecting patient affordability. The company's low beta of -0.07 suggests it is less volatile than the market, potentially offering a more stable investment option. Bumrungrad's ability to maintain its competitive edge through continuous innovation and service excellence will be crucial for sustained growth.

BUHPF在哪个行业运营？

Bumrungrad Hospital operates within the growing medical care facilities industry, driven by increasing healthcare demand in Thailand and the broader Southeast Asia region. The industry is characterized by technological advancements, rising medical tourism, and an aging population requiring more healthcare services. Competition includes both local and international hospitals, with key players focusing on specialized treatments and patient experience. Bumrungrad distinguishes itself through its international accreditation and focus on medical tourism, catering to a global patient base seeking high-quality healthcare services. The company's ability to adapt to changing healthcare regulations and technological advancements will be crucial for maintaining its competitive edge.

Medical - Care Facilities

Healthcare

BUHPF有哪些增长机遇？

Expansion of International Patient Services: Bumrungrad has a significant opportunity to further expand its services to international patients, particularly from regions with limited access to advanced medical treatments. By strengthening its marketing efforts and partnerships with international healthcare providers, Bumrungrad can attract a larger patient base seeking specialized medical care in Thailand. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth avenue for Bumrungrad.
Development of Specialized Medical Centers: Investing in the development of specialized medical centers focused on specific medical disciplines, such as oncology, cardiology, and orthopedics, can attract more patients seeking advanced treatments. By offering comprehensive care within these specialized centers, Bumrungrad can enhance its reputation as a center of medical excellence and attract both domestic and international patients. This targeted approach allows for efficient resource allocation and specialized expertise.
Adoption of Advanced Medical Technologies: Integrating advanced medical technologies, such as robotic surgery, AI-powered diagnostics, and telemedicine, can improve treatment outcomes and enhance patient experience. By investing in these technologies, Bumrungrad can attract patients seeking cutting-edge medical solutions and differentiate itself from competitors. The global market for AI in healthcare is expected to reach $34 billion by 2025, indicating a significant opportunity for technological integration.
Strategic Partnerships and Acquisitions: Forming strategic partnerships with other healthcare providers, insurance companies, and medical tourism agencies can expand Bumrungrad's reach and patient base. Acquiring smaller hospitals or clinics can also provide access to new markets and specialized services. These collaborations can enhance Bumrungrad's market presence and service offerings, driving revenue growth and market share.
Enhancement of Digital Healthcare Services: Expanding digital healthcare services, such as online consultations, remote monitoring, and digital health records, can improve patient access and convenience. By offering these services, Bumrungrad can cater to a wider patient base and enhance patient engagement. The global digital health market is projected to reach $660 billion by 2025, indicating a significant opportunity for Bumrungrad to leverage digital technologies to enhance its services.

Market Cap of $4.49B reflects Bumrungrad's significant presence and value in the healthcare industry.
P/E Ratio of 17.64 suggests a reasonable valuation compared to its earnings.
Profit Margin of 29.8% demonstrates strong operational efficiency and profitability.
Gross Margin of 51.8% indicates effective cost management and pricing strategies.
Dividend Yield of 8.41% provides a substantial return to investors, highlighting the company's commitment to shareholder value.

BUHPF提供哪些产品和服务？

Operates a large medical center in Bangkok, Thailand.
Provides diagnostic, therapeutic, and intensive care facilities.
Offers a wide range of outpatient clinics and centers specializing in various medical disciplines.
Caters to both domestic and international patients.
Engages in real estate asset management related to healthcare facilities.
Provides clinical research services.
Distributes pharmaceutical and medical goods through specialized stores.
Operates a personnel development and training center for healthcare services.

BUHPF如何赚钱？

Generates revenue through patient fees for medical services.
Attracts international patients seeking specialized treatments.
Operates outpatient clinics and centers for various medical specialties.
Distributes pharmaceutical and medical goods through specialized stores.

Domestic patients in Thailand seeking medical care.
International patients seeking specialized treatments and medical tourism.
Insurance companies and healthcare providers.
Patients seeking outpatient services and specialized medical centers.

Established reputation and brand recognition as a leading healthcare provider in Thailand.
Accreditation and international standards of medical care.
Comprehensive range of medical services and specialized centers.
Strategic location in Bangkok, a hub for medical tourism.

什么因素可能推动BUHPF股价上涨？

Upcoming: Expansion of specialized medical centers to attract more patients.
Ongoing: Increasing demand for healthcare services in Thailand and the region.
Ongoing: Growth in medical tourism and international patient services.
Upcoming: Adoption of advanced medical technologies to improve treatment outcomes.
Ongoing: Strategic partnerships and acquisitions to expand market reach.

BUHPF的主要风险是什么？

Potential: Economic downturns affecting patient affordability and demand for medical services.
Potential: Changes in healthcare regulations and policies.
Ongoing: Increased competition from other healthcare providers.
Potential: Political instability and security risks in the region.
Ongoing: Dependence on international patients, making it vulnerable to travel restrictions.

BUHPF的核心优势是什么？

Strong brand reputation and international accreditation.
Comprehensive range of medical services and specialized centers.
Experienced medical professionals and staff.
Strategic location in Bangkok, a hub for medical tourism.

BUHPF的劣势是什么？

Dependence on international patients, making it vulnerable to travel restrictions and economic fluctuations.
High operating costs associated with maintaining international standards.
Competition from other healthcare providers in the region.
Potential regulatory challenges in the healthcare industry.

BUHPF有哪些机遇？

Expansion of services to new markets and regions.
Development of specialized medical centers and advanced treatments.
Adoption of digital healthcare technologies and telemedicine.
Strategic partnerships and acquisitions to expand market reach.

BUHPF面临哪些威胁？

Economic downturns affecting patient affordability and demand for medical services.
Changes in healthcare regulations and policies.
Increased competition from other healthcare providers.
Political instability and security risks in the region.

BUHPF的竞争对手是谁？

Apollo Medical Holdings, Inc. — Focuses on coordinated care and value-based healthcare. — (AMFPF)
Czumak Holding AG — Operates in the healthcare sector with a focus on medical technology. — (CZMWF)
Czumak Holding AG (ADR) — ADR of Czumak Holding AG, providing access to international investors. — (CZMWY)
LVZ-Life Invest Assets AG — Invests in healthcare properties and facilities. — (LVZPF)
Nihon Kohden Corporation — Develops, manufactures, and distributes medical electronic equipment. — (NHNKY)

Key Metrics

MoonshotScore: 47/100

Company Profile

CEO: Artirat Charukitpipat
Headquarters: Bangkok, TH
Founded: 2010

AI Insight

AI analysis pending for BUHPF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Bumrungrad Hospital Public Company Limited do?

Bumrungrad Hospital Public Company Limited operates as a leading healthcare provider in Thailand, offering a comprehensive range of medical services to both domestic and international patients. The company's business model revolves around providing high-quality medical care through its network of specialized clinics and centers, catering to various medical disciplines. Bumrungrad generates revenue through patient fees for medical services, attracting international patients seeking specialized treatments, and operating outpatient clinics and centers for various medical specialties. The company also distributes pharmaceutical and medical goods through specialized stores, enhancing its service offerings.

What do analysts say about BUHPF stock?

Analyst consensus on BUHPF stock is currently unavailable due to limited coverage. However, key valuation metrics such as the P/E ratio of 17.64 and a dividend yield of 8.41% offer insights into the company's financial performance. Growth considerations include the increasing demand for healthcare services in Thailand and the expansion of its international patient base. Investors should conduct their own due diligence and consider the risks associated with investing in an OTC-listed company with limited financial disclosure before making any investment decisions. Further AI analysis is pending for BUHPF.

What are the main risks for BUHPF?

The main risks for Bumrungrad Hospital Public Company Limited include economic downturns affecting patient affordability and demand for medical services, changes in healthcare regulations and policies, and increased competition from other healthcare providers in the region. The company's dependence on international patients also makes it vulnerable to travel restrictions and economic fluctuations. Additionally, as an OTC-listed company, BUHPF faces risks associated with limited financial disclosure, low liquidity, and reduced regulatory oversight, which can increase the potential for price volatility and information asymmetry. Investors should carefully assess these risks before investing in BUHPF.